Switzerland

Biognosys announces Strategic Partnership with Alamar Biosciences for Precision Medicine Research

Biognosys announces Strategic Partnership with Alamar Biosciences for Precision Medicine Research

Biognosys, a frontrunner in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a pioneer in precision proteomics for early disease detection, have forged a strategic alliance to prop

BMC’s 257 AMP AL One e-bike tailored for Urban Riders

BMC’s 257 AMP AL One e-bike tailored for Urban Riders

BMC, a Swiss bicycle brand renowned for its high-performance road and mountain bikes, has announced the launch of its latest offering, the sleek and tech-savvy 257 AMP AL One electric bicycle (e-bi

ABB to supply charging infrastructure for VDL’s autonomous e-vehicle fleet at Singapore port

ABB to supply charging infrastructure for VDL’s autonomous e-vehicle fleet at Singapore port

In a recent announcement, Switzerland-based multinational corporation ABB has revealed that it has received a new order pertaining to the supply of charging infrastructure for a fleet of autonomous

Leclanché to supply battery systems to Bombardier for rail projects

Leclanché to supply battery systems to Bombardier for rail projects

In a press release, Germany-based train manufacturer Bombardier Transportation -- a division of Canadian firm Bombardier Incorporated -- has disclosed that it has signed an agreement with Swiss bat

UBS confirms slashing 2,000 jobs in US

 UBS confirms slashing 2,000 jobs in US Zurich  - UBS, the troubled Swiss banking giant, confirmed reports Thursday that it was in the process of cutting 2,000 jobs in its wealth management division in the United States.

"This part of the headcount reduction initiative," said a UBS spokesman in Switzerland.

The company, the largest manager of wealth in the world, announced earlier this month that it will take a first-quarter loss of almost 2

billion Swiss francs (1.7 billion dollars) and cut 8,700 jobs worldwide by 2010, including over 2,000 in its base of Switzerland.

Novartis developing new flu vaccine

 Novartis developing new flu vaccine Geneva - Swiss drugmaker Novartis said Thursday it was in the process of developing a vaccine with a booster that could inoculate against all known H5N1 antigenic variants, or all types of avian influenza.

A study mixing Aflunov, an investigative pre-pandemic avian influenza vaccine, with a Novartis adjuvant, "elicited a long-lasting immune response that could be rapidly boosted following a single dose of the vaccine."

The booster shot could be taken up to six years after the original vaccine was administered.

Pages